Study: China Names Cancer, Strokes Two Most Fatal Diseases
This article was originally published in PharmAsia News
Executive Summary
A Chinese study names cancer and stroke the nation's top fatal diseases, with respiratory and heart disease following, in that order. The two-year research project by the Ministry of Health estimated 85 percent of deaths of Chinese were due to those four diseases and the fifth-highest fatality, injuries and poisoning. The report said the incidence of stroke is five times what has been recorded in Europe and the United States and its cancer rate is near that of the United States, United Kingdom and France. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.